No one will be sad to see the back of a horrendous year, with the raging pandemic bringing the world to its knees. However, the potential end to this dire situation is now tantalizingly in sight. The collective sigh of relief was certainly demonstrated by investors. According to Cowen & Co. analysts, “the sector had its strongest rally since the Spring and the biotech indices kept pace with the broader markets."